Evofem Biosciences, Inc. (EVFM) › Operating Cash FlowEvofem Biosciences, Inc. (EVFM) — Operating Cash FlowAnnual figures by period end, from SEC filings.2018-12-31: -$56.50M2019-12-31: -$55.10M2020-12-31: -$104.83M2021-12-31: -$146.67M2022-12-31: -$70.41M2023-12-31: -$8.97M2024-12-31: -$3.88M2025-12-31: -$1.99M-$1.99M2018-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$1.99M—2026-03-11From 2025-01-012024-12-31-$3.88M—2026-03-11From 2024-01-012023-12-31-$8.97M—2025-03-24From 2023-01-012022-12-31-$70.41M—2024-03-27From 2022-01-012021-12-31-$146.67M—2023-04-27From 2021-01-012020-12-31-$104.83M—2022-03-10From 2020-01-012019-12-31-$55.10M—2021-03-04From 2019-01-012018-12-31-$56.50M—2020-03-12From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)